Larimar Therapeutics Inc. sell goldmanns
Start price
18.02.24
/
0%
€12.10
Target price
18.02.25
-
Performance (%)
-74.55%
End price
19.02.25
€3.08
Summary
This prediction ended on 19.02.25 with a price of €3.08. goldmanns correctly predicted massive losses of -74.55% for Larimar Therapeutics Inc.. This prediction was marked as speculative and is excluded from goldmanns's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Larimar Therapeutics Inc. | 16.541% | 16.541% | -8.824% |
| iShares Core DAX® | -1.764% | 2.259% | 15.847% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 4.686% |
| iShares Nikkei 225® | -2.451% | 4.086% | 16.083% |
| iShares S&P 500 | -2.252% | -0.151% | 1.636% |
Comments by goldmanns for this prediction
In the thread Zafgen Inc. diskutieren
Sell Larimar Therapeutics Inc.
In the thread Trading Zafgen Inc.
Die von goldmanns gewählte maximale Laufzeit wurde überschritten